Disruption of hippocampal-prefrontal cortex activity by dopamine D2R-dependent LTD of NMDAR transmission. by Banks, Paul J. et al.
Disruption of hippocampal–prefrontal cortex activity
by dopamine D2R-dependent LTD of
NMDAR transmission
Paul James Banksa, Amelia Caroline Burroughsa, Gareth Robert Isaac Barkera, Jon Thomas Brownb,
Elizabeth Clea Warburtona, and Zafar Iqbal Bashira,1
aSchool of Physiology and Pharmacology, University of Bristol, Bristol, BS8 1TD, United Kingdom; and bInstitute of Biomedical and Clinical Sciences,
University of Exeter Medical School, Exeter, EX4 4PS, United Kingdom
Edited by Roberto Malinow, University of California, San Diego, La Jolla, CA, and approved July 27, 2015 (received for review June 25, 2015)
Functional connectivity between the hippocampus and prefrontal
cortex (PFC) is essential for associative recognition memory and
working memory. Disruption of hippocampal–PFC synchrony oc-
curs in schizophrenia, which is characterized by hypofunction of
NMDA receptor (NMDAR)-mediated transmission. We demonstrate
that activity of dopamine D2-like receptors (D2Rs) leads selectively
to long-term depression (LTD) of hippocampal–PFC NMDAR-mediated
synaptic transmission. We show that dopamine-dependent LTD of
NMDAR-mediated transmission profoundly disrupts normal synaptic
transmission between hippocampus and PFC. These results show
how dopaminergic activation induces long-term hypofunction of
NMDARs, which can contribute to disordered functional connec-
tivity, a characteristic that is a hallmark of psychiatric disorders
such as schizophrenia.
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The hippocampus to medial prefrontal cortex (PFC) pro-jection is important for executive function and working and
long-term memory (1, 2). Glutamatergic neurons of the ventral
hippocampal cornu ammonis 1 (CA1) region project directly to
layers 2–6 of ipsilateral PFC, and this connection synchronizes
PFC and hippocampal activity during particular behavioral condi-
tions (3–5). Disruption of hippocampal–PFC synchrony is asso-
ciated with cognitive deficits that occur in disorders such as
schizophrenia (6). Hippocampal–PFC uncoupling can be achieved
by NMDA receptor (NMDAR) antagonism (7), and NMDAR
hypofunction is a recognized feature of schizophrenia (8). However,
it is unclear, first, how changes in NMDAR function at this
synapse may arise, and second, how NMDAR hypofunction af-
fects hippocampal–PFC synaptic transmission.
Canonically, NMDARs are considered to contribute little to
single synaptic events, but the slow kinetics of NMDARs con-
tribute to maintaining depolarization, leading to the generation
of bursts of action potentials (9–13). Furthermore, NMDARs
coordinate spike timing relative to the phase of field potential
oscillations (14, 15). NMDAR transmission itself undergoes
synaptic plasticity (16, 17), and this can have a profound effect
on sustained depolarization, burst firing, synaptic integration,
and metaplasticity (9, 11, 18, 19). In PFC, NMDARs are oppo-
sitely regulated by dopamine receptors; D1-like receptors (D1Rs)
potentiate and D2-like receptors (D2Rs) depress NMDAR cur-
rents (20). Interestingly, NMDAR hypofunction (8, 21) and do-
pamine D2 receptor activity (22) are potentially converging
mechanisms contributing to schizophrenia (23).
We now examine the contribution of NMDARs to transmission
at the hippocampal–PFC synapse. We show that NMDAR activity
provides sustained depolarization that can trigger action potentials
during bursts of hippocampal input to PFC. We next demonstrate
that dopamine D2 receptor-dependent long-term depression
(LTD) of NMDAR transmission profoundly attenuates summation
of synaptic transmission and neuronal firing at the hippocampal–
PFC input. These findings allow for a mechanistic understanding
of how alterations in dopamine and NMDAR function can lead to
the disruption of hippocampal–PFC functional connectivity, which
characterizes certain psychiatric disorders.
Results
Role of NMDARs in Hippocampal–PFC Synaptic Transmission. In this
study, we focus on the contribution of NMDARs to synaptic
transmission at the hippocampal–PFC synaptic input. Experi-
ments were conducted in slices of rat prefrontal cortex in which
hippocampal–PFC fibers are preserved (see refs. 24, 25; Fig. S1
and Table S1). Layer 5 pyramidal neurons were current clamped
at −70 mV, and single stimuli were applied to the hippocampal
fiber tract [evoked excitatory postsynaptic potential (EPSP)
mean amplitude, 3.2 ± 0.9 mV; n = 10]. The application of the
NMDAR antagonist (D)-2-amino-5-phosphonopentanoic acid
(AP5) did not affect peak EPSP amplitude (108 ± 16%; Fig. 1A;
P = 0.6), but significantly reduced the 90–10% decay time of
single EPSPs (from 67 ± 11 to 34 ± 4 ms, reduction to 56 ± 6%
of control; Fig. 1A; P = 0.003), demonstrating NMDAR contri-
bution to the duration of depolarization during a single EPSP.
To examine the contribution of NMDAR activation to the
summation of bursts of synaptic events, we delivered trains of 10
stimuli at different frequencies to the hippocampal afferents and
measured the area under the summed EPSPs. AP5 significantly
attenuated the synaptic response to 20 Hz (36 ± 6% of control;
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Fig. 1 B and C; P = 0.008, paired t test), but not to 50 Hz (55 ±
11% of control; Fig. 1 B and C; P = 0.14) or 100 Hz (87 ± 23%;
Fig. 1 B and C; P = 0.2; n = 10) stimulation.
As an alternative measure of summation of synaptic trans-
mission, we determined the effect of AP5 on the amplitude of
each EPSP during the bursts. This analysis was only performed
on those cells that did not fire action potentials during the
stimulation (n = 7/10). At 20 Hz stimulation, but not at 50 or
100 Hz, there was an overall decrease in temporal summation of
EPSPs in the presence of AP5 compared with control conditions.
In some cells (3/10), burst stimulation of hippocampal affer-
ents produced sufficient depolarization to elicit action potential
firing. The presence of AP5 reduced the number of action po-
tentials per stimulus train (Fig. S2A).
Thus, NMDAR-mediated transmission makes a significant
frequency-dependent contribution to the synaptic activity of PFC
neurons during hippocampal burst firing. In addition, NMDAR-
mediated transmission makes a significant contribution to PFC
neuronal spiking in response to hippocampal bursts.
LTD of NMDAR-Mediated Synaptic Transmission.Given the importance
of NMDAR-mediated transmission to synaptic transmission during
hippocampal burst activity demonstrated earlier, we examined how
LTD of NMDAR-mediated transmission would affect hippocampal–
PFC transmission. To first determine that plasticity of NMDAR
transmission can occur at the hippocampal–PFC synapse, NMDAR-
mediated EPSCs (EPSCNMDA) were isolated by voltage-clamping
cells at −40 mV and blocking AMPAR- and GABAAR-mediated
synaptic transmission with 5 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahy-
drobenzo[f]quinoxaline-7-sulfonamide (NBQX) and 50 μM picro-
toxin, respectively.
Theta-frequency stimulation (TFS; 300 stimuli, 5 Hz, test in-
tensity) resulted in lasting LTD of EPSCNMDA (to 58.5 ± 5.3% of
baseline; Fig. 2A), which was not associated with a significant
change in EPSC decay [baseline weighted tau = 164 ± 21 ms;
post-TFS Tw = 204 ± 39 ms; paired t test t(9) = −0.95; P = 0.4],
indicating that LTD was unlikely to be associated with a switch in
NMDAR subunits.
Importantly, TFS had no effect on EPSCAMPA (95.6 ± 6.4%;
Fig. 2B). A two-way ANOVA (factors: receptor, stimulation)
revealed a statistically significant interaction [F(1,36) = 15.9; P <
0.001], indicating that TFS induces LTD specifically of NMDAR-
mediated transmission. Furthermore, the paired pulse ratio of
EPSCNMDA was not altered by TFS [baseline = 1.61 ± 0.1; post-
TFS = 1.85 ± 0.18; n = 6; paired t test t(5) = −1.4; P = 0.22]. This
also suggests it is unlikely that LTD of EPSCNMDA is a result of a
decrease in transmitter release.
We next examined which transmitters/receptors are responsible
for LTD of EPSCNMDA. Bath application of D2-like dopamine
receptor antagonist sulpiride (10 μM) completely blocked the
induction of LTD of EPSCNMDA (Fig. 2 C and F) but had no
effect on basal transmission or maintenance of LTD (Fig. S3 A
and B). In contrast, D1R-like antagonist SCH23390 (10 μM) did
not block LTD (Fig. 2 C and F). Furthermore, the D1R-like
agonist SKF81297 (0.5 μM) had no effect on EPSCNMDA (Fig.
S4A), suggesting a differential role for D1 and D2Rs in regulation
of NMDA receptors. Furthermore, bath application of the D2R
agonist quinpirole (10 μM) also depressed EPSCNMDA (55.4 ±
2.8% of baseline; Fig. 2D). Delivery of TFS after quinpirole LTD
had no significant effect on EPSCNMDA amplitude (60.6 ± 3.9%;
Fig. 2D), suggesting quinpirole and TFS-LTD share common
mechanisms. Together, these results suggest dopamine D2 re-
ceptors are critical for activity-dependent LTD of EPSCNMDA.
To examine whether LTD of EPSCNMDA relied on NMDAR
activation, neurons were voltage clamped at −100 mV during
TFS, at which holding potential no EPSCNMDA was observed
(Fig. S3C, Inset). Under these conditions, the induction of LTD
still occurred (Fig. 2E, TFS at −100 mV; Fig. S3C). As a control,
we show that hyperpolarization to −100 mV in the absence of
TFS had no lasting effect on synaptic transmission (Fig. 2E,−100 mV
control; Fig. S3C). Finally, delivering TFS in the presence of 50 μM
AP5 did not prevent induction of LTD (Fig. 2E; AP5 + TBS; Fig.
S3D). Together, these results suggest that LTD of EPSCNMDA does
not require NMDAR activation.
We further investigated involvement of other G protein-coupled
receptors in induction of NMDAR-LTD. Neither of the muscarinic
receptor antagonists atropine (1 μM; Fig. 2F and Fig. S4B) and
scopolamine (10 μM; Fig. 2F and Fig. S4C) prevented the in-
duction of activity-dependent LTD. In addition, the broad-spectrum
mGluR antagonist LY341495 (100 μM) did not prevent the induc-
tion of LTD (Fig. 2F and Fig. S4D).
D2-like dopamine receptors are coupled with inhibition of the
adenylyl cyclase-cAMP-protein kinase A (PKA) pathway (20, 22,
26). Consistent with a key role of D2-like receptors in the gen-
eration of NMDAR-LTD, inhibition of PKA by bath application
of H89 (10 μM) or KT5720 (200 nM) resulted in a slowly de-
veloping LTD of EPSCNMDA (Fig. 3A). Furthermore, prior ac-
tivation of D2-like receptors with quinpirole markedly reduced
subsequent depression by H89 (Fig. 3B), implying that D2 acti-
vation induces LTD via inhibition of PKA activity. Consistent
with the lack of effect of the D1-like agonist SKF81297 upon
EPSCNMDA, the PKA agonist forskolin (10 μM) did not produce
lasting effects on basal EPSCNMDA amplitude (Fig. 3C). Appli-
cation of forskolin resulted in de-depression of EPSCNMDA when
applied after prior TFS (Fig. S4E), implicating PKA inhibition in
activity-dependent LTD of EPSCNMDA. Previous studies have
indicated that activation of glycogen synthase kinase3-beta
(GSK3β) can result in depression of NMDAR transmission (27).
However, we found that LTD of EPSCNMDA was unaffected by
Fig. 1. NMDAR inhibition reduces temporal summation of hippocampal–PFC
transmission. (A) AP5 (50 μM) reduces 90–10% decay time of single EPSPs [n =
10; paired t test t(9) = 3.96; P = 0.003] without affecting peak amplitude [t(9) =
0.50; P = 0.63]. (Inset) Before and after AP5 application. (B) Effect of AP5 on the
area under the curve of EPSP bursts at different frequencies (n = 10). AP5 at-
tenuates area under the curve at 20 Hz [paired t test t(9) = 3.39; P = 0.008], but
not at 50 Hz [t(9) = 1.63; P = 0.14] or 100 Hz [t(9) = 1.36; P = 0.21]. (C) Analysis of
peak amplitude of each response during 20-, 50-, and 100-Hz bursts (nonspiking
cells only, n = 7). Consistent with a lack of effect on single EPSP amplitude,
response 1 was not affected by AP5 at 20 Hz [paired t test, t(6) = 1.98; P = 0.095],
50 Hz [t(6) = 1.84; P = 0.12], or 100 Hz [t(6) = 0.29; P = 0.78]. Two-way repeated
measures ANOVA (factors: drug, response number; Greenhouse-Geisser cor-
rection applied) of responses 2–10 showed a main effect of response number at
20 Hz [F(1.13,6.81) = 8.92; P = 0.019], a main effect of drug [F(1,6) = 20.73; P =
0.004], and crucially, a drug × response number interaction [F(8,14.66) = 3.72; P =
0.042]. At 50 Hz, a main effect was shown for both factors [response number
F(1.06,6.37) = 16.36 (P = 0.019); drug F(1,6) = 11.05 (P = 0.016)], but no interaction
was observed [F(1.632,9.791) = 0.753; P = 0.471]. At 100 Hz, a main effect was
shown for response number [F(1.36,8.14) = 22.16; P = 0.001], but not for drug
[F(1,6) = 0.778; P = 0.412], and there was no interaction [F(1.66,9.94) = 0.99; P = 0.389].
(Insets) Example traces from same cell shown in A. (Scale bars, 100 ms/1 mV.)
*/** = P < 0.05/0.01, respectively.
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either of the GSK3β inhibitors 2-methyl-4-(phenylmethyl)-1,2,4-
thiadiazolidine-3,5-dione (TDZD-8) or SB216763 (Fig. S3F). In
addition, inclusion of 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-
tetraacetic acid (BAPTA) in the patch pipette did not prevent the
induction of LTD (10 mM; Fig. 3D). Thus, brief, 5-Hz stimulation
results in LTD of EPSCNMDA that relies on dopamine D2 re-
ceptor activation and inhibition of cAMP/PKA.
Disruption of Hippocampal–PFC Transmission by LTD of NMDARs.We
next examined the effects of TFS-induced LTD of NMDARs on
single EPSPs and temporal summation of EPSPs at 20, 50, and
100 Hz at the hippocampal–PFC synapse 30–40 min after TFS. No
change in peak amplitude of single EPSPs was detected after TFS
(Fig. 4A). However, the decay time of single EPSPs was signifi-
cantly decreased after TFS (Fig. 4A). The effects of TFS on peak
amplitude and EPSP decay are consistent with the effects of AP5
on single EPSPs (Fig. 1A). Therefore, these data suggest that, as
with the voltage-clamp experiments, TFS also induces robust LTD
of NMDAR-mediated transmission under the current clamp con-
ditions of the present experiments. In addition, these data also
show that TFS is without effect on AMPAR-mediated transmission,
which is consistent with the experiments showing that TFS delivered,
under voltage-clamp conditions, results in LTD of EPSCNMDA, but
not EPSCAMPA. (Fig. 2 A and B)
We then investigated the effects of NMDAR-LTD on sum-
mation of EPSPs (Fig. 4 B and C). Summation of synaptic
transmission during 20-Hz stimulation was significantly reduced
after TFS (area under the curve, 51.4 ± 4.6%; Fig. 4 B and C).
Peak-by-peak analysis of EPSP trains evoked at 20 Hz also
showed that amplitudes of responses 2–10 were reduced after
TFS (Fig. 4C). Furthermore, TFS altered the short-term plas-
ticity of the 20-Hz train (response × TFS interaction P = 0.042).
TFS significantly reduced synaptic summation at 50 Hz, as
measured by the area under the curve (67 ± 19%; Fig. 4B);
however, no significant effect was observed when analyzing peak
amplitudes of burst responses (Fig. 4C). Summation of 100-Hz
synaptic stimuli was not significantly affected by NMDAR-LTD
(Fig. 4 B and C).
In four of 11 experiments, burst stimulation of hippocampal
afferents produced sufficient depolarization to elicit spiking
under control conditions (Fig. S2B). After TFS induced LTD of
EPSCNMDA, there was a reduction in the average number of
action potentials per train of EPSPs (Fig. S2B).
Together, these results demonstrate that LTD of NMDAR
transmission can disrupt, in a frequency-dependent manner, sum-
mation of hippocampal–PFC synaptic transmission and can atten-
uate subsequent action potential firing.
Disruption of Hippocampal–PFC Transmission by LTD of NMDARs Is
Dependent on Activation of Dopamine D2Rs. Finally, we examined
whether the disruption of synaptic transmission that occurred
after TFS stimulation could be prevented by blocking LTD of
EPSCNMDA. Thus, the experiments described earlier were re-
peated in the presence of 10 μM sulpiride to block D2R-
dependent induction of NMDAR-LTD. Under these conditions,
TFS had no effect on EPSP decay (94 ± 7% of baseline; Fig. 5A).
Summation of EPSPs in response to bursts of synaptic stimuli
was not significantly reduced at any firing frequency, as measured
Fig. 2. TFS induces D2R-dependent LTD of EPSCNMDA, but not of EPSCAMPA. (A) Three hundred stimuli delivered at 5 Hz (TFS; delivered at time = 0 min, filled
circles) induced LTD of hippocampal–PFC EPSCNMDA (depressed to 58.5 ± 5.3% of baseline; n = 10). Open circles: time-matched control NMDA EPSCs (89.3 ±
3.5%; n = 13). (B) TFS does not depress EPSCAMPA (filled circles; 95.6 ± 6.4%; n = 10) compared with time-matched control EPSCAMPA (open circles; 85.3 ± 8.2%;
n = 7). (C) Induction of NMDAR-LTD was prevented by prior bath application (shaded region) of the D2-like dopamine receptor antagonist sulpiride (10 μM;
filled circles; 96.3 ± 4.0%; n = 5; one-way ANOVA, Bonferroni post hoc vs. TFS alone; P < 0.001), whereas D1-like dopamine receptor antagonist SCH23390
(10 μM) failed to block induction of NMDAR-LTD (open circles, 43.4 ± 6.2%; n = 5; P = 1.0). (D) Bath application of D2-like dopamine receptor agonist quinpirole
(10 μM) significantly depressed EPSCNMDA (55.4 ± 2.8%; n = 5; Bonferroni vs. control P = 0.001). Subsequent TFS failed to further depress EPSCNMDA [60.6 ±
3.9%; paired t test t(4) = −1.14; P = 0.316]. (E) Summary of data in A and Fig. S3. LTD of EPSCNMDA by TFS does not require NMDAR activation. Hyperpo-
larization of cell to −100 mV during TFS does not prevent induction of NMDAR-LTD, and hyperpolarization to −100 mV alone does not alter EPSCNMDA
amplitude. Blockade of NMDARs with AP5 (50 μM) before TFS does not prevent induction of NMDAR-LTD compared with AP5 applied without TFS. [One-way
ANOVA, main effect F(5,42) = 14.62; P < 0.001.] (F) Summary of data in C and D and Fig. S4. Bath application of D2R antagonist sulpiride prevents induction of
NMDAR-LTD by TFS, whereas inhibition of D1Rs (SCH23390) does not. Pharmacological activation of D2Rs (quinpirole) induces LTD, but activation of D1Rs
(SKF81297) has no effect. Muscarinic acetylcholine receptors (atropine, scopolamine) and mGluRs (LY341495) are not required for TFS-induced plasticity. One-
way ANOVA main effect [F(8,50) = 14.76; P < 0.001]. */**/*** = P < 0.05/0.01/0.001, respectively, Bonferroni post hoc compared against control group unless
otherwise indicated. (Insets) Representative traces at baseline (black) and 46–60 min (gray).
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by area under curve (Fig. 5B) or by EPSP peak amplitudes (Fig.
5C). Finally, action potential firing was not altered after TFS in
the presence of sulpiride (Fig. S2C).
These data show that activation of D2Rs results in LTD of
NMDAR transmission that disrupts hippocampal–PFC synaptic
activity. These results provide an insight into potential mecha-
nisms by which dopamine receptor hyperfunction and NMDAR
hypofunction might underlie the disruption of hippocampal–PFC
synchrony that occurs in schizophrenia.
Discussion
The results of this study show that synaptic transmission from
hippocampus to PFC is critically dependent on the activation of
NMDARs in a frequency-dependent manner. Disruption of hip-
pocampal–PFC transmission occurs after attenuation of NMDAR
activity after application of AP5 or LTD of NMDAR-mediated
synaptic transmission that relies critically on the activation of do-
pamine D2Rs. These results show that alterations in NMDAR
function brought about by D2Rs contribute to disordered func-
tional connectivity between hippocampus and PFC, a characteristic
that is a hallmark of disorders such as schizophrenia.
NMDARs and Transmission Between Hippocampus and PFC. The
hippocampal–PFC connection is critical in associative learning
(2), and synchronization of PFC–hippocampal activity is impor-
tant for working memory (5, 28, 29). We found that bursts of
EPSPs at lower (20 Hz), but not higher (50 or 100 Hz), frequency
are highly sensitive to NMDAR antagonism. Thus, NMDARs
play a crucial role in determining the synaptic activity profile
between hippocampus and PFC, maintaining the postsynaptic
cell at depolarized membrane potential longer during 20 Hz
transmission. Frequencies of ∼20 Hz occur in the hippocampus
during spatial navigation (30), so NMDARs control synaptic
transmission at physiologically relevant frequencies. In addition,
NMDAR activation also contributed to spike firing in layer 5
PFC pyramidal neurons during bursting activity. Therefore,
NMDAR activity controls hippocampal–PFC synaptic trans-
mission and regulates the output of PFC pyramidal cells. Hence,
NMDAR-dependent regulation of transmission between hippo-
campus and PFC may play an important role in associative and
working memory.
LTD of EPSCNMDA. Our data show that activity-dependent LTD of
EPSCNMDA at the hippocampal–PFC synapse relies on endoge-
nous activation of D2Rs. This significantly extends the physiolog-
ical relevance of previous studies demonstrating that activation of
D2Rs by exogenous agonists can depress NMDA agonist currents
or NMDA EPSCs (27, 31–33). In contrast to the report that in 9–
10-mo-old mice only a subpopulation of PFC pyramidal neurons
express D2Rs (34), we found that in every case tested, LTD was
D2R-dependent. Therefore, under the conditions of our experi-
ments, it is unlikely that a large proportion of pyramidal neurons
lack D2Rs. In contrast to previous reports of D1R-mediated en-
hancement of NMDAR transmission (20, 35), the application of a
D1 agonist had no effect on the hippocampal–PFC EPSCNMDA in
the present study. Although changes in NMDAR function in the
hippocampus have been demonstrated to be dependent on mus-
carinic (36) and group I mGluR activation (37) the activity-
dependent LTD in our study did not rely on activation of either of
these receptor types.
Different mechanisms for D2R-dependent depression of NMDA
responses have been suggested previously (32, 38). Although
we were not able to confirm a role for GSK3β (27) in the D2R-
dependent LTD of EPSCNMDA, our results showing that the PKA
inhibitor H89 depresses EPSCNMDA are consistent with a D2R-
dependent inhibition of cAMP/PKA signaling being critical for
Fig. 4. TFS-induced NMDAR-LTD impairs temporal summation during burst
stimulation. (A) TFS reduces the decay time of single EPSPs [57.1 ± 7.3% of
baseline; n = 11; paired t test, t(10) = 5.49; P < 0.001] without affecting peak
amplitude [99 ± 7%; t(10) = 0.99; P = 0.345]. (B) Thirty minutes after TFS, the
area under the curve of 20 Hz [paired t test, t(10) = 4.64; P = 0.001] and 50 Hz
[t(10) = 3.10; P = 0.011] synaptic bursts was reduced, whereas at 100 Hz, no
effect was observed [t(10) = 0.313; P = 0.761]. (C) Analysis of peak amplitude
of each response during different frequency bursts (nonspiking cells only,
n = 8 at 20 Hz; n = 7 at 50 and 100 Hz). Statistical analysis showed that the
amplitude of response 1 was not affected by TFS at any frequency [repeated
measures ANOVA 20 Hz: F(2,16) = 0.8 (P = 0.5); 50 Hz: F(2,12) = 1.1 (P = 0.4);
100 Hz: F(1.170,7.020) = 2.6 (P = 0.15)]. Two-way repeated-measures ANOVA
(factors: TFS, response number; Greenhouse-Geisser correction applied) of
responses 2–10 in the 20-Hz burst showed a main effect of response number
[F(1.895,13.262) = 15.7; P < 0.001] and of TFS [F(1,7) = 73.0; P < 0.001] and a
response × TFS interaction [F(2.030,14.210) = 3.3; P = 0.042]. At 50 Hz, a main
effect of response number was found [F(2.275,13.653) = 12.1; P = 0.001]; how-
ever, no significant main effect of TFS [F(1,6) = 5.3; P = 0.061] or interaction
[F(2.221,13.325) = 1.1; P = 0.4] was observed. At 100 Hz, effects were not sig-
nificant for response number [F(1.762,10.57) = 3.6; P = 0.07], TFS [F(1,6) = 0.8; P =
0.4] or their interaction [F(2,11.997) = 2.4; P = 0.13]. */**/*** = P < 0.05, P <
0.01, P < 0.001, respectively. (Insets) Representative traces at baseline (black)
and after TFS (gray). (Scale bars, 2 mV/100 ms.)
Fig. 3. NMDAR-LTD is mediated by PKA. (A) Inhibition of PKA mimicked the
effect of D2-like dopamine receptor agonist quinpirole, producing a slowly
developing LTD of EPSCNMDA in response to either H89 [10 μM; 58.7 ± 4.7%;
n = 5; one-way ANOVA main effect F(7,53) = 13.76; P < 0.001; Bonferroni vs.
control, P = 0.01] or KT5720 (200 nM; 63.6 ± 5.3%; n = 5; Bonferroni vs.
control, P = 0.028). (B) D2-like dopamine agonist quinpirole (10 μM, light
gray shading and trace) depressed EPSCNMDA to 64.2 ± 3.8% (n = 5). Sub-
sequent application of PKA inhibitor H89 (10 μM, dark gray shading and
trace) resulted in a small further depression to 55.7 ± 2.5% of baseline
[paired t test t(4) = 6.06; P = 0.004]. The effect of H89 after quinpirole (8.6 ±
1.4% depression) was significantly smaller than that of H89 applied alone
[38.8 ± 5.1% depression; t test t(8) = 5.67; P < 0.001]. (C) PKA agonist for-
skolin induced a transient potentiation of EPSCNMDA (10 μM; amplitude
6–20 min postdrug = 128.4%; P = 0.001), which returned back to baseline
levels within an hour of washout (107.3 ± 5.5%; n = 8; P = 0.26). (D) Inclusion
of calcium chelator BAPTA in the intracellular recording solution did not
prevent induction of NMDAR-LTD by TFS (10 mM; 61.7 ± 5.6%; n = 5; Bon-
ferroni vs. TFS: P = 1.0). (Insets) Representative traces at baseline (black) and
46–60 min (gray). (Scale bars, 40 pA/100 ms.)
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LTD (38). This finding for layer 5 PFC pyramidal cells is in contrast
to a previous report suggesting a lack of cAMP/PKA signaling in
D2R inhibition of NMDA currents in CA1 pyramidal neurons (31),
but is in keeping with the mechanisms proposed to underlie the
D2R-dependent decrease in NMDAR-dependent calcium influx in
striatopallidal neurons (39).
That TFS resulted in LTD selectively of EPSCNMDA, but not
of EPSCAMPA, indicates that LTD of NMDA transmission is not
likely to rely on a decrease in transmitter release (39). Several
mechanisms have been postulated for LTD of NMDARs, in-
cluding internalization of receptors (37), diffusion of receptors to
extrasynaptic sites (40), or a switch in NMDAR subunits (41). A
recent report has suggested that prolonged D2R activation can
decrease surface expression of NR2B-containing NMDARs in
the CA1 region of hippocampus (42), and evidence suggests
NR2B subunits have greater lateral mobility than NR2A (43).
However, we found that LTD was not associated with a change
in decay kinetics of EPSCNMDA, suggesting no change in NMDAR
subunit composition in our experiments. PKA activity has been
shown to enhance NMDAR function via phosphorylation of NR1,
NR2A, and NR2B subunits (44–46); thus, a reduction in PKA
activity and subsequent dephosphorylation of NMDARs may
provide a potential mechanism underlying the decrease in NMDAR
currents (44).
Consequences of LTD of NMDAR for Synaptic Transmission. Activity-
dependent plasticity of NMDAR transmission occurs at many syn-
apses and can lead to metaplasticity (11, 18, 19). NMDAR plasticity
may also play a homeostatic role. Plasticity of NMDAR transmission
can accompany that of AMPA receptor (AMPAR) transmission,
thereby preserving the AMPAR:NMDAR ratio (47). However, as
TFS did not induce plasticity of AMPAR-mediated transmission, it
is unlikely that the activity-dependent LTD of NMDARs fulfils a
homeostatic function at the hippocampal–PFC input.
Aside from metaplasticity, a consequence of the long-term
plasticity of NMDA transmission is the effect on synaptic trans-
mission. We demonstrate that the normal EPSP summation and
spike firing in layer 5 pyramidal neurons, driven by bursts of
activity in hippocampal afferents, is significantly attenuated after
activity-dependent LTD of NMDAR transmission. Previous
studies have underlined the importance of NMDAR trans-
mission in temporal summation between pairs of PFC pyramidal
neurons, where they may play a key role in recurrent excitation
(48) and persistent firing (49). Such effects may contribute to
working memory processes in PFC. NMDA receptors also play a
key role in integration of synaptic input in dendritic branches
(10) and in the generation of plateau potentials, which can result
in somatic spiking (50). Although temporal summation did not
result in spiking in the majority of cases in this study, probably
because of the relatively modest EPSP amplitude (∼2–3 mV),
NMDAR-mediated transmission may facilitate spatiotemporal
integration of separate inputs in hippocampal neurons (51).
Correspondingly, NMDAR LTD is likely to profoundly affect
the input–output characteristics of PFC neurons receiving direct
input from the hippocampus.
Implications of D2R-Induced LTD of NMDA. Dysfunction of the PFC
is a widely reported phenomena in schizophrenia, in which
the role of PFC in executive function and working memory is
thought to be disrupted. Traditionally, hypotheses concerning
mechanisms of schizophrenia have focused on dysfunction of the
dopaminergic and glutamatergic systems, with D2R-like receptor
hyperactivity (52) and NMDAR hypofunction (8, 53) being key
features. Recently, it has been shown that cotreatment of pa-
tients with schizophrenia with both D2R-like antagonists and
agents that increase NMDAR coagonist activity, such as D-serine
or glycine transporter antagonists, are more effective than either
treatment alone (54–56), supporting hypotheses of schizophrenia
that include interaction of dopamine and NMDAR systems
(21, 57, 58).
Here we present evidence that NMDAR transmission is a key
driver of normal EPSP summation and action potential firing at
the hippocampal–PFC projection where glutamatergic and do-
paminergic projections converge on layer 5 pyramidal neurons
(59, 60). D2R activation leads to a long-lasting reduction of
NMDAR function in the hippocampal–PFC pathway that criti-
cally disrupts temporal summation at the hippocampal–PFC
synapse and can lead to decreased PFC spiking in response to
bursts of hippocampal activity. As there is evidence showing the
importance of hippocampal–PFC signaling in working memory
(5, 28, 29), associative memory (2), and executive function (61),
cognitive faculties negatively affected in schizophrenia, we hypoth-
esize that D2R-induced NMDAR hypofunction at the hippocampal–
PFC pyramidal cells is a key dysfunction in the pathology of
schizophrenia.
Materials and Methods
Animals. Experiments were conducted in male pigmented rats (Lister Hooded
strain) postnatal day 30–32. All experiments were performed in accordance with
the U.K. Animals (Scientific Procedures) Act 1986 and associated guidelines and
had approval from the University of Bristol Ethics Committee. All efforts were
made to minimize suffering and the number of animals used.
Electrophysiology. Rats were decapitated under isoflurane anesthesia, and
the brain was removed and rapidly submerged in ice-cold (2–4 °C) oxygen-
ated (95% O2–5% CO2) artificial cerebrospinal fluid (aCSF) containing (in
mM): 124 NaCl, 3 KCl, 26 NaHCO3, 1.25 NaH2PO4, 1 MgSO4, 10 D-glucose,
and 2 CaCl2. The brain was cut at an 11° modified coronal angle using a
custom brain matrix (Zivic Instruments), and 400-μm slices were made
using a vibratome before storing in room temperature aCSF for ≥1 h before
use. Slices equivalent to +2.7 to +2.2 mm from bregma were perfused
with aCSF at 2 mL/min. Whole-cell patch clamp recordings were made
from layer 5 neurons using 2–6-MΩ glass pipettes filled with either cesium
Fig. 5. D2R antagonism blocks TFS-induced effects on NMDAR transmission
and TFS reduction in temporal summation. (A) In the presence of D2-like
dopamine receptor antagonist sulpiride, TFS affects neither the peak am-
plitude [n = 7; paired t test, t(6) = 0.33; P = 0.75] nor the decay time of in-
dividual EPSPs [t(6) = 0.419; P = 0.69]. (Inset) Example EPSPs. (B) When
delivered in the presence of sulpiride (10 μM), TFS had no effect on area
under the curve of synaptic bursts at 20 [paired t test, t(6) = 1.36; P = 0.22], 50
[t(6) = 1.42; P = 0.21], or 100 [t(6) = 1.55; P = 0.17] Hz. (C) Response by re-
sponse analysis of temporal summation (nonspiking cells only) showed
that peak amplitude changed as a function of response number at 20 Hz
[two-way repeated-measures ANOVA, main effect of response number
F(2.381,16.667) = 16.0; P < 0.001], 50 Hz [F(1.625,9.751) = 14.1; P = 0.002), and 100
Hz [F(1.274,6.371) = 8. 3; P = 0.023]; however, in the presence of sulpiride, no
main effect of TFS was observed at any frequency [20 Hz: n = 7; F(1,7) = 4.7;
P = 0.067; 50 Hz: n = 6, F(1,6) = 1.8, P = 0.2; 100 Hz: n = 6, F(1,6) = 1.8, P = 0.2],
nor were response × TFS interactions seen [20 Hz: F(1.723,12.063) = 1.7 (P = 0.2);
50 Hz: F(2.482,14.892) = 0.3 (P = 0.8); 100 Hz: F(1.492,7.460) = 2.9 (P = 0.12)]. (Insets)
Representative traces at baseline (black) and after TFS (gray). (Scale bars,
2 mV/100 ms.)
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methylsulfonate-based solution (voltage clamp) or potassium gluconate-
based solution (current clamp). Hippocampal–PFC responses were evoked
by applying 0.1-ms constant current pulses to the hippocampal fiber tract,
using a concentric bipolar stimulating electrode (24). Where applicable,
NMDAR-mediated currents were isolated by bath application of picro-
toxin (50 μM) and NBQX (5 μM) and voltage clamp of cells at −40 mV.
Detailed information on electrophysiology and analysis can be found in SI
Materials and Methods.
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SI Materials and Methods
General Surgical Procedure. All surgical procedures were per-
formed on male Lister-hooded rats that weighed 300–400 g at
the start of the procedure. Each rat was anesthetized with iso-
flurane [induction, 4% (vol/vol); maintenance, 2–3%] and se-
cured in a stereotaxic frame with the incisor bar set at 3.3 mm
below the interaural line. Injections of tracer or neurotoxin were
made through burr holes at the coordinates outlined here. At the
end of surgery, each animal received fluid replacement therapy
(5 mL saline containing 1% glucose s.c.) and analgesia (0.05 mL
Vetgesic i.m.).
Hippocampal Tracer Injection.Anterograde tracer (200 nL dextran-
conjugated AlexaFluor488 4% in PBS; Life Technologies) was
injected into the ventral hippocampus (−6.5 mm from bregma,
−4.5 mm from midline, 6.4 mm below dura at an angle of 10° to
the vertical plane) by pressure injection, using an UltraMicroPump
3 (World Precision Instruments) fitted with a 5-μL Hamilton
syringe with a 33-gauge needle at a rate of 50 nL/min, with the
needle left in situ for 10 min postinjection. Animals were anes-
thetized with sodium pentobarbital 7 d later and transcardially
perfused with PBS followed by 4% paraformaldehyde and post-
fixed in paraformaldehyde for 24 h and then transferred to 30%
sucrose in 0.2 M phosphate buffer for 48 h before making coronal
sections (40 μm) on a cryostat. Sections were mounted with Vec-
tashield mounting medium (Vector Labs) containing 1.5 μg/mL
DAPI. Images were obtained using a Leica DFC3000 FX
camera mounted on a Leica DM5000B microscope with Leica
GFP and A4 filter sets used to observe AlexaFluor488 and
DAPI, respectively.
Hippocampal Lesions. Unilateral hippocampal excitotoxic lesions
were made in six 300–400-g rats by making a series of injections
of NMDA, as indicated in Table S1. Modified coronal slices
were cut, as detailed here, 21–28 d after the lesions, and elec-
trophysiological recordings were made from both hemispheres of
PFC. The remaining tissue was fixed in paraformaldehyde for
48 h, transferred to 30% sucrose in 0.2 M PBS for 48 h, and
sectioned at 40 μm on a cryostat before staining with cresyl vi-
olet. To determine the extent of the lesions, the remaining hip-
pocampal tissue was measured in each hemisphere (Leica Qwin
3) in every fifth section between −1.9 and −6.3 mm relative to
bregma, and the remaining hippocampal tissue from the lesioned
hemisphere was expressed as a percentage of hippocampal tissue
in the opposite hemisphere of the same sections.
Slice preparation. Animals were anesthetized with isoflurane and
decapitated. The brain was rapidly removed and placed in ice-
cold (2–4 °C) oxygenated (95% O2–5% CO2) aCSF containing
(in mM): 124 NaCl, 3 KCl, 26 NaHCO3, 1.25 NaH2PO4, 1
MgSO4, 10 D-glucose, and 2 CaCl2. The brain was cut at an 11°
modified coronal angle, as described previously for the mouse
(24), using a custom brain matrix (Zivic Instruments), and slices
were cut at 400 μm using a vibratome before storing in room
temperature aCSF for ≥1 h before use.
Electrophysiology. Slices equivalent to +2.7 to +2.2 mm from
bregma (62) were transferred to a submerged recording chamber
and perfused with aCSF at a rate of 2 mL/min. For voltage-
clamp experiments, layer 5 neurons were patch clamped in the
whole-cell configuration, using borosilicate glass (GC150F-10;
Harvard Apparatus) electrodes 2–6 MΩ filled with a cesium
methylsulfonate-based solution (in mM: 130 CsMeSO4,
8 NaCl, 10 Hepes, 0.5 EGTA, 4 Mg-ATP, 0.3 Na-GTP, 5 QX-314-
Cl at pH 7.25, 280–295 mOsm) at room temperature. Recordings
were obtained using an Axon Multiclamp 700B amplifier (Mo-
lecular Devices) and WinLTP v1.11b (63) or pClamp 10
(Molecular Devices) acquisition software, filtered at 4 kHz and
digitized at 20 kHz (Digidata 1322A; Molecular Devices) with-
out liquid junction potential correction. Cells in which series
resistance exceeded 30 MΩ or changed >20% were discarded. A
concentric bipolar stimulating electrode (CBAPB50; FHC) was
placed on the hippocampal fiber bundle, and synaptic responses
were evoked using 0.1-ms constant-current pulses. Picrotoxin
(50 μM) and NBQX (5 μM) were bath applied and cells were
held at −40 mV to isolate EPSCNMDA. Activity-dependent LTD
was induced by delivery of 300 pulses at 5 Hz at baseline stimulus
intensity.
Current clamp recordings were performed at 31 ± 1 °C, using a
potassium gluconate-based intracellular solution (in mM: 145
K-gluconate, 5 NaCl, 10 Hepes, 0.5 EGTA, 4 Mg-ATP, 0.3 Na-
GTP at pH 7.25, 280–295 mOsm) and were acquired using
pClamp10.2 software (Molecular Devices) low-pass filtered at
4 kHz and digitized at 100 kHz. Cells were held at −70 mV by
injecting constant current (liquid junction potentials corrected
post hoc), and single hippocampal–PFC EPSPs were evoked at
0.1 Hz before delivering synaptic trains of 10 stimuli delivered at
20, 50, and 100 Hz. In some experiments, NMDA receptors were
blocked pharmacologically by bath applying 50 μM D-AP5 for
10 min before repeating synaptic measurements. In other ex-
periments, TFS was applied by switching to voltage-clamp and
stimulating 300 times at 5 Hz at Vholding = −40 mV. Single re-
sponses and trains were then remeasured in current clamp dur-
ing a 10-min period immediately after TFS, and again in a
10-min period 30 min after TFS.
Analysis. Data were analyzed using WinLTP and Clampfit (Mo-
lecular Devices) and statistical analysis using SPSS 21 (IBM).
Results are expressed as mean ± SEM unless indicated other-
wise. Statistical analysis of current clamp data were performed
using repeated-measures ANOVA or paired t test. Statistical
analysis of plasticity experiments was assessed by averaging data
points from the last 15 min of the experiment, using one-way
ANOVA with Bonferroni post hoc comparisons to allow in-
clusion of a control data group to account for effects of rundown.
EPSCNMDA decay time constants were fit by a double expo-
nential function using Clampfit and a weighted time constant
(τw) calculated as τw = τfast*[Afast/(Afast + Aslow)]+ τslow*[Aslow/
(Aslow + Afast)], where A = amplitude. τw were compared using
paired t tests. Statistical significance was set at 0.05 for all
comparisons. Statistical analysis of the effects of hippocampal
lesions on electrophysiology were performed using Mann–Whitney
nonparametric test.
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Fig. S1. Recording of hippocampal–PFC synaptic transmission in the rat in vitro. After labeling of the ventral hippocampal CA1 region with an anterograde
tracer (A), fibers were observed running in a ventral–dorsal course (B, Bottom Right) and innervated infralimbic and prelimbic cortex (B, Top Right). Stimulation
electrode is placed within hippocampal fiber bundle, and recordings made from prelimbic layer 5. (C) To confirm the origin of the putative hippocampal fiber
bundle, unilateral excitotoxic lesions were made in six animals. Twenty-one days later, volumetric lesion analysis showed 61 ± 8% of hippocampal volume was
lost. Largest (gray) and smallest (black) lesion volumes are shown. (D) In PFC slices contralateral to the lesion, stimulation of hippocampal afferents evoked
large EPSCs in all cells (mean amplitude, 299 ± 45 pA; n = 17 cells from six animals), whereas in slices from the ipsilateral hemisphere, responses were absent or
profoundly reduced in amplitude (38 ± 8.4 pA; n = 19 cells from six animals) compared with the contralateral hemisphere (Mann–Whitney test, ***P < 0.001).
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Fig. S2. Effects of NMDA receptor modulation on action potential firing. (A, Left) Plot of action potentials fired during synaptic bursts at different frequencies
before and after bath application of AP5 (50 μM), averaged across three cells. (Right) Example trace of a cell that fires in response to a 20-Hz synaptic burst
before, but not after, AP5. (B, Left) Action potentials fired before and after TFS averaged across four cells. (Right) Example traces of cell spiking in response to a
50-Hz synaptic burst with spiking attenuated after TFS. (C, Left) A single cell fired in response to 50- and 100-Hz synaptic bursts both before and after delivery
of TFS in the presence of sulpiride. (Right) Example traces of 50-Hz bursts before and after TFS + sulpiride. Because of low experimental number, statistical
analyses were not performed on these data.
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Fig. S3. D2-like dopamine receptor activation does not regulate basal NMDA transmission nor expression of NMDA-LTD, and induction of NMDA-LTD does
not require activation of NMDARs. (A) Bath application of sulpiride (10 μM) had no effect on basal EPSCNMDA transmission [93.8 ± 4.5% of baseline; n = 5;
paired t test t(4) = −1.127; P = 0.32]. (B) The maintenance of LTD of EPSCNMDA (45.2 ± 8.2% of baseline; n = 6) is unaffected by sulpiride (10 μM), when bath
applied 30 min later [44.7 ± 10.3% of baseline; paired t test t(5) = 0.192; P = 0.86]. (C) Hyperpolarization of cell to −100 mV during TFS (shaded region)
prevented ionic conductance through NMDARs (dark gray trace, inset), but did not prevent induction of NMDAR-LTD (filled circles, 57.4 ± 5.5% of baseline; n =
5; one-way ANOVA, Bonferroni post hoc vs. TFS, P = 1.0). Hyperpolarization to −100 mV in the absence of TFS was not sufficient to induce NMDAR-LTD (open
circles, 87.1 ± 8.8%; n = 4; post hoc vs. TFS, P = 0.002; post hoc vs. control, P = 1.0). See Fig. 2E for summary. (D) Bath application of AP5 (50 μM, shaded region)
before delivery of TFS did not prevent induction of LTD (filled circles, 56.4 ± 4.8%; n = 8; Bonferroni post vs. TBS alone, P = 1.0; control, P < 0.001). Furthermore
TFS applied in the presence of AP5 was significantly different than a control group AP5 applied in the absence of TFS (open circles, 74.6 ± 2.7%; n = 8;
Bonferroni post hoc, P = 0.041). The AP5 control group was not significantly different to time matched controls (P = 0.11). See Fig. 2E for summary. (Insets)
Representative traces at baseline (black) and 46–60 min (gray).
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Fig. S4. (A) D1R-like dopamine receptor agonist SKF81297 (0.5 μM) had no effect on EPSCNMDA (98.9 ± 8.6% of baseline; n = 5; one way-ANOVA, Bonferroni
vs. control, P = 1.0, vs. TFS, P < 0.001). Bath application of muscarnic acetylcholine receptor antagonists (B) atropine (1 μM, 52.7 ± 4.6%; n = 5; post hoc vs. TFS
alone, P = 1.0) or (C) scopolamine (10 μM, 55.2 ± 9.4%; n = 6; post hoc vs. TFS alone, P = 1.0) did not prevent induction of LTD by TFS. (D) Bath application of
LY341495 at a concentration (100 μM) that acts as a broad-spectrum mGluR antagonist did not prevent activity-dependent NMDAR-LTD (70.1 ± 4.6%; n = 5;
post hoc vs. TFS alone, P = 1.0). (E) LTD of EPSCNMDA by TFS (64.8 ± 2.1%; n = 5; light gray trace) was reversed by bath application of forskolin [10 μM, dark gray
trace, 90.8 ± 10.8% of baseline, paired t test, t(4) = −2.79; P = 0.495]. (F) NMDAR-LTD induced by TFS was not blocked by bath application of GSK3β antagonists
TDZD-8 (10 μM; 58.5 ± 7.1%; n = 6; Bonferroni vs. TFS, P = 1.0) or SB216763 (10 μM; 60.7 ± 5.6%; n = 9; post hoc vs. TFS alone, P = 1.0). (Insets) Representative
traces at baseline (black) and 46–60 min (gray). (A–D are summarized in Fig. 2F).
Table S1. Injection coordinates for unilateral hippocampal
lesions
AP ML DV Volume, μL
−3.15 ±1.0 −3.5 0.1
−3.45 ±1.0 −3.7 0.1
−3.45 ±2.5 −3.6 0.1
−4.75 ±2.5 −3.0 0.1
−4.75 ±4.0 −3.2 0.1
−4.75 ±5.5 −4.0 0.1
−5.25 ±2.5 −3.4 0.1
−5.25 ±4.5 −4.0 0.15
−5.95 ±4.6 −4.2 0.15
−6.35 ±4.8 −5.0 0.15
−6.55 ±4.8 −6.5 0.15
−6.75 ±4.8 −6.5 0.15
Excitotoxic lesions were achieved by microinjection at 12 sites of 0.06 M
NMDA dissolved in saline. Injections were made at a rate of 0.05 μL/min, and
the needle was left in situ for either 2 (0.1 μL) or 3 min (0.15 μL). AP, ante-
roposterior; DV, dorsoventral; ML, mediolateral.
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